Add BrightSurf on Google Email

Pediatric Investigation study reports significant shifts in post-COVID respiratory infection trends in children

A recent study found significant changes in post-COVID respiratory infections among children, with Mycoplasma pneumoniae experiencing a surge after restrictions were lifted. The study also revealed strong interactions between pathogens, including negative correlations and pathogen interference.

SourcePediatric Investigation·JournalPediatric Investigation·TypeObservational study·DateFeb 2, 2026

Wastewater surveillance reveals true scale of COVID-19 spread as clinical testing declines

A study in Japan found that wastewater surveillance can uncover the true scale of COVID-19 spread by detecting high viral loads in sewage despite reduced clinical testing. This approach offers an objective view of community-wide infection levels, unaffected by changes in testing policies or public behavior.

SourceThe University of Osaka·JournalEnvironment International·TypeObservational study·DateJan 28, 2026

Nearly half of CDC surveillance databases have halted updates, raising concerns about health data gaps

Nearly half of CDC surveillance databases have stopped updating, primarily tracking vaccination-related information and respiratory diseases. Prolonged pauses risk weakening evidence-based decision-making, and the authors recommend clear status updates, reasons for delays, and timelines for resuming data publication.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJan 26, 2026

Double trouble: Tobacco use and Long COVID

Current smokers are more likely to experience four symptoms associated with Long COVID, including arthralgia, chest pain and dyspnea. Dual users of combustible and heated tobacco products also show a stronger correlation with symptoms, suggesting the added use may worsen symptoms.

SourceOsaka Metropolitan University·JournalScientific Reports·TypeData/statistical analysis·DateJan 26, 2026

Team-based primary care strategy cuts hepatitis C virus treatment delays by four months

A family medicine interdisciplinary team improved hepatitis C virus treatment outcomes by streamlining medication access and reducing administrative burdens. The team's strategy, implemented at an urban clinic in Ohio, resulted in a significant reduction of treatment delays from over 6 months to under 2 months.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJan 26, 2026

Microneedle technology for overcoming biological barriers: Advancing biomacromolecular delivery and therapeutic applications in major diseases

Researchers explore microneedle technology as a novel delivery system for efficient and minimally invasive intradermal drug delivery. The review highlights the design of functional microneedles with specific structures to overcome biological barriers in various tissues, improving therapeutic outcomes.

SourceResearch·JournalResearch·TypeNews article·DateJan 21, 2026

Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognized transmission

Researchers found that some healthy Nigerian adults showed clear evidence of new immune boosting consistent with recent mpox exposure without recorded diagnoses. This suggests that exposure may occur without recognized disease, highlighting the need for monitoring populations by testing blood samples for antibodies.

SourceUniversity of Cambridge·JournalNature Communications·TypeObservational study·DateJan 20, 2026

Can Canada’s health systems handle increased demand during FIFA World Cup?

A recent editorial cautions that Canada's health systems may struggle to cope with the influx of patients during the upcoming FIFA World Cup. The article highlights concerns about overburdened hospitals and emergency departments, as well as the need for a national plan to bolster capacity and train personnel.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeCommentary/editorial·DateJan 19, 2026

NTU Singapore scientists find new way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Researchers at NTU Singapore have found that a common bacterium produces reactive oxygen species that impairs wound healing. Neutralizing this process with an antioxidant enzyme restores skin cells' ability to migrate and heal, offering a potential solution to tackle antibiotic-resistant strains.

SourceNanyang Technological University·JournalScience Advances·TypeExperimental study·DateJan 16, 2026

Itaconate modifications: mechanisms and applications

Researchers summarize itaconate biology highlighting its chemical reactivity and therapeutic potential in treating infectious diseases, sepsis, autoimmunity, neurodegenerative disorders. Itaconate exerts biological effects through post-translational modifications, altering protein activity and signaling pathways

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeLiterature review·DateJan 15, 2026

Lifesaving breakthrough in bacterial behavior

Researchers have made a groundbreaking discovery about how bacteria swim upstream to cause infections, pointing to new designs for biomedical devices that can prevent contamination. The study found that wider channels with faster counterflows are more prone to invasion, but sharp corner designs can inhibit bacterial growth.

SourceUniversity of Pennsylvania·JournalNewton·TypeExperimental study·DateJan 12, 2026

The secret route of prostate infections

Researchers developed a lab-grown model of the prostate gland to study bacterial infections. They found that E. coli targets specific cells and uses a 'lock and key' principle to invade. A sugar molecule called D-mannose blocks this interaction, offering a potential new strategy to prevent and treat prostate infections.

SourceUniversity of Würzburg·JournalNature Microbiology·TypeExperimental study·DateJan 12, 2026

Some antibodies outmaneuver germs from sticking to cells

Researchers discovered that certain antibodies employ unusual tactics to block bacterial adhesion, including creating molecular wedges and conformational traps. These mechanisms could lead to the development of immune therapies targeting glycan-binding cell-attachment proteins produced by bacteria causing urinary tract infections.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalNature Communications·TypeExperimental study·DateJan 7, 2026

How the parasite that ‘gave up sex’ found more hosts – and why its victory won’t last

A research team at the Walter and Eliza Hall Institute has discovered a genetic mechanism that allows certain parasites to infect multiple hosts, but at the cost of long-term survival. The study sheds light on how parasitic infections emerge and spread, with potential implications for public health surveillance and treatment strategies.

SourceWalter and Eliza Hall Institute·JournalNature Communications·TypeObservational study·DateJan 6, 2026

High levels of Chagas disease parasite found in bugs near U.S.-Mexico border

A UTEP study has discovered a significant increase in parasitic infection rates among kissing bugs in the Borderlands, raising concerns about local transmission of Chagas disease. The research suggests that the disease is becoming an increasingly public health issue for the Southwest, affecting approximately 6 million people worldwide.

SourceUniversity of Texas at El Paso·JournalEpidemiology and Infection·DateJan 6, 2026

Bats identified as origin of unexplained acute respiratory illness and encephalitis in Bangladesh

Researchers detected Pteropine orthoreovirus (PRV) in five patients in Bangladesh with symptoms consistent with Nipah virus infection. The study highlights the importance of broad-spectrum surveillance programs to identify and mitigate public health risks from emerging bat-borne viruses.

SourceColumbia University's Mailman School of Public Health·JournalEmerging Infectious Diseases·TypeObservational study·DateJan 5, 2026

Why Some Bacteria Survive Antibiotics and How to Stop Them - New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes”

Researchers identify two archetypes of growth arrest that lead to persistence: regulated and disrupted states. The former provides protection from antibiotics, while the latter is marked by vulnerabilities, particularly impaired cell membrane stability. This distinction has significant implications for developing targeted therapies.

SourceThe Hebrew University of Jerusalem·JournalScience Advances·TypeExperimental study·DateJan 2, 2026

Shifting pathways: Community and healthcare-associated transmission of mpox in the Democratic Republic of the Congo and Europe

Researchers describe first reported mpox transmission of clade Ib in a healthcare setting outside Africa, with Ireland's nosocomial outbreak linked to local cases. In the Democratic Republic of Congo, community transmission shifted from sexual to non-sexual routes, driven by factors like overcrowding and child malnutrition.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeObservational study·DateDec 19, 2025

The antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella

A study published in the International Journal of Infectious Diseases found that delafloxacin inhibits Legionella replication more effectively than levofloxacin. The antibiotic demonstrates promising intracellular activity, which could support further clinical investigation as a potential treatment for Legionnaires' disease.

SourceGermans Trias i Pujol Research Institute·JournalInternational Journal of Infectious Diseases·TypeExperimental study·DateDec 17, 2025

Streptococcus suis serotype 2 collagenase-like protease promotes meningitis by increasing blood-brain barrier permeability

A study found that Streptococcus suis serotype 2 collagenase-like protease enhances virulence and tissue colonization, promoting BBB destruction and increased permeability. The protein also induced apoptosis in brain microvascular endothelial cells and infiltrated immune cells into the brain after infection.

SourceKeAi Communications Co., Ltd.·JournalJournal of Integrative Agriculture·TypeExperimental study·DateDec 15, 2025

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID

The Lundquist Institute's second-generation fungal vaccine candidate, VXV-01, is moving forward in development after securing a $40 million NIH/NIAID contract. The vaccine aims to elicit robust immunity against opportunistic and hospital-associated pathogens.

Canada’s reduced pledge to Global Fund will impact domestic health

A reduced pledge by Canada to the Global Fund could lead to decreased success in controlling tuberculosis and HIV/AIDS in the country. The authors of an editorial urge Canada's government to invest in improving social determinants of health and implement disease-specific suggestions to address these pressing global health issues.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeCommentary/editorial·DateDec 15, 2025

Influenza clade K viruses prolong the influenza season in Australia and New Zealand

The emergence of A(H3N2) subclade K viruses in Australia and New Zealand extended their influenza seasons, with Australia experiencing a record-breaking season. The viruses were likely imported from the US and accounted for half of Australian viruses and over two-thirds of New Zealand viruses.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateDec 11, 2025

Cardiovascular events 1 year after RSV infection in adults

A cohort study of adults aged 45 or older with RSV infection found a significant excess risk of cardiovascular events over 1 year, comparable in magnitude to influenza infection. This highlights the importance of RSV as a potential risk factor for cardiovascular morbidity and underscores the need for vaccination to mitigate this burden.

SourceJAMA Network·JournalJAMA Network Open·DateDec 8, 2025